|Pulmonary Edema Global Clinical Trials Review, H2, 2015 by ReportBazzar.|
The clinical trial report, “Pulmonary Edema Global Clinical Trials Review, H1, 2015″ provides an overview of Pulmonary Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Edema. Report ...
Medgadget.com (blog) - Mon, 05 Oct 2015 11:33
|pulmonary edema market report serves as an excellent guide to market strategies|
Pharmaceuticals_0133 Pulmonary edema is considered a leading cause of deaths among cardiovascular diseases. The global market for pulmonary edema is chiefly driven by the rising prevalence of cardiac attacks and other associated diseases, changing ...
Medgadget.com (blog) - Tue, 08 Sep 2015 12:45
|Navjot Singh Sidhu hospitalised with DVT-- Can you get it too?|
What's more travelling to such an altitude also puts a person at risk of suffering from three life threatening conditions, namely — High Altitude Illness (HAI), High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE). All of which ...
TheHealthSite - Tue, 06 Oct 2015 22:26
|Research delivers insight into the pulmonary edema global clinical market ...|
This report provides top line data relating to the clinical trials on Pulmonary Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request For Sample Report Here: ...
WhaTech - Mon, 21 Sep 2015 16:03
|Champion Recruit of Police Squad 89 dies at KHMH|
Terry reported that she had been diagnosed with a variety of illnesses – pulmonary edema, cardiomyopathy, vein thrombosis, enlarged liver and pulmonary and thromboembolism. She had reportedly been suffering from an enlarged heart which led to her ...
Amandala - Tue, 06 Oct 2015 14:56
|Skip vasoreactivity testing in connective tissue disease PAH work-up|
It's important to rule out pulmonary venous occlusive disease (PVOD) before treating PAH. “These are patients who behave like PAH, but they have pulmonary venule involvement,” as well, and can be thrown into pulmonary edema by specific PAH therapies.
Family Practice News Digital Network - Mon, 05 Oct 2015 12:52
|FDA Clears Two-Drug Combo as First-Line Treatment for PAH|
The US Food and Drug Administration (FDA) has approved the use of ambrisentan (Letairis, Gilead Sciences) in combination with tadalafil (Adcirca, Eli Lilly) as up-front therapy for pulmonary arterial hypertension (PAH) to reduce the risk of worsening ...
Medscape - Mon, 05 Oct 2015 11:07
|Gilead Sciences (GILD) Announces FDA Approval of Letairis Combo as PAH Treatment|
StreetInsider.com - Mon, 05 Oct 2015 03:23
|US Food and Drug Administration Approves New Treatment Combination of Gilead's ...|
PharmaLive (press release) (subscription) - Fri, 02 Oct 2015 15:18
|US FDA approves Gilead's Letairis in combo with tadalafil to treat pulmonary ...|
pharmabiz.com - Mon, 05 Oct 2015 00:30
|Exercise For Pulmonary Hypertension|
Exercise is one of the behavioral alterations that, when medically supervised, can help patients improve symptoms like shortness of breath (dyspnea); fatigue; dizziness or fainting spells (syncope); pressure or pain in the chest; swelling (edema) in ...
Pulmonary Hypertension News - Tue, 06 Oct 2015 04:48